Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis

This study has been completed.
Sponsor:
Information provided by:
Bayhill Therapeutics
ClinicalTrials.gov Identifier:
NCT00382629
First received: September 27, 2006
Last updated: February 7, 2008
Last verified: February 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: June 2007
  Estimated Primary Completion Date: No date given